The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

To accomplish this, a retrospective case series study was conducted involving 76 patients previously diagnosed with dry eye and exhibiting unsatisfactory responses to various prior clinical treatments ...

Flu cases are climbing and experts are warning vaccine rates against the potentially deadly infection are “alarmingly low” as ...

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...